|
Volumn 206, Issue 3, 2009, Pages 494-495
|
Clifton E. Barry, III: TB's strategic opponent
|
Author keywords
[No Author keywords available]
|
Indexed keywords
6,7 DIHYDRO 2 NITRO 6 (4 TRIFLUOROMETHOXYBENZYLOXY) 5H IMIDAZO[2,1 B][1,3]OXAZINE;
BCG VACCINE;
BACTERIAL GENOME;
CLINICAL TRIAL;
DRUG RESEARCH;
DRUG SENSITIVITY;
DRUG TARGETING;
HOST PATHOGEN INTERACTION;
HUMAN;
MYCOBACTERIUM TUBERCULOSIS;
NONHUMAN;
NOTE;
PRIORITY JOURNAL;
PROFESSIONAL PRACTICE;
TUBERCULOSIS;
ANIMAL;
ARTICLE;
HISTORY;
INTERVIEW;
MOUSE;
UNITED STATES;
ANIMALS;
HISTORY, 20TH CENTURY;
HISTORY, 21ST CENTURY;
HUMANS;
MICE;
TUBERCULOSIS;
UNITED STATES;
|
EID: 63449087052
PISSN: 00221007
EISSN: 15409538
Source Type: Journal
DOI: 10.1084/jem.2063pi Document Type: Note |
Times cited : (1)
|
References (5)
|